about
Long-term analgesic effect of clodronate in rodentsPolymeric nanoparticles enhance the sonodynamic activity of meso-tetrakis (4-sulfonatophenyl) porphyrin in an in vitro neuroblastoma modelSimultaneous HPLC determination of 5-fluorouracil and its metabolites in plasma of cancer patients.Targeted treatment of folate receptor-positive platinum-resistant ovarian cancer and companion diagnostics, with specific focus on vintafolide and etarfolatide.Innovative formulations for the controlled and site-specific delivery of antiinflammatory drugs.Pharmacogenetics of drug-metabolizing enzymes in Italian populations.Selective sensitiveness of mesenchymal stem cells to shock waves leads to anticancer effect in human cancer cell co-cultures.Squaraines bearing halogenated moieties as anticancer photosensitizers: Synthesis, characterization and biological evaluation.High energy shock waves and 5-aminolevulinic for sonodynamic therapy: effects in a syngeneic model of colon cancer.Cytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell line.Solid lipid nanoparticles delivering anti-inflammatory drugs to treat inflammatory bowel disease: Effects in an in vivo model.Acquired Hemophilia A May Be Associated with Ticagrelor Therapy in a 52-Year-Old Man After a Recent Percutaneous Transluminal Coronary Angioplasty.UPLC-MS/MS method for quantification of the azathioprine metabolites 6-mercaptoguanosine and 6-methylmercaptopurine riboside in peripheral blood mononuclear cells.Solid lipid nanoparticles as anti-inflammatory drug delivery system in a human inflammatory bowel disease whole-blood model.Prospective study of the effects of concomitant medications on thiopurine metabolism in inflammatory bowel disease.Analysis of CYP2C9*5 in Caucasian, Oriental and black-African populations.Dexibuprofen (S+-isomer ibuprofen) reduces gastric damage and improves analgesic and antiinflammatory effects in rodents.Determination of disodium clodronate in human plasma and urine using gas-chromatography-nitrogen-phosphorous detections: validation and application in pharmacokinetic study.Cholesteryl butyrate solid lipid nanoparticles as a butyric acid pro-drug: effects on cell proliferation, cell-cycle distribution and c-myc expression in human leukemic cells.Plasma concentrations of 5-fluorouracil and its metabolites in colon cancer patients.Enhanced selective sonosensitizing efficacy of ultrasound-based anticancer treatment by targeted gold nanoparticles.Engineered porphyrin loaded core-shell nanoparticles for selective sonodynamic anticancer treatment.High energy shock waves (HESW) increase paclitaxel efficacy in a syngeneic model of breast cancer.Surface modification and cellular uptake evaluation of Au-coated Ni80Fe20 nanodiscs for biomedical applications.Sonoluminescence and acoustic emission spectra at different stages of cavitation zone development.Thiopurine S-methyltransferase pharmacogenetics in a large-scale healthy Italian-Caucasian population: differences in enzyme activity.Modulation of butyrate anticancer activity by solid lipid nanoparticle delivery: an in vitro investigation on human breast cancer and leukemia cell lines.Expression of CYP3A isoforms and P-glycoprotein in human stomach, jejunum and ileum.High energy shock waves (HESW) for sonodynamic therapy: effects on HT-29 human colon cancer cells.Expression of cytochromes P450 3A and P-glycoprotein in human large intestine in paired tumour and normal samplesBiological Effect Evaluation of Glutathione-Responsive Cyclodextrin-Based Nanosponges: 2D and 3D Studies
P50
Q28165627-1F0ED4DD-98EA-4845-890E-42E2D58A51B9Q30447211-F776D09E-DAC0-4844-87E3-B261978C6EBAQ30863244-80D83095-8DDA-4DC7-AB45-1D2D40BEB65DQ37567078-3583C29F-F0BE-49B9-941C-727C912B8796Q38089214-3C202541-D038-4C93-867D-2DADE5E92AE7Q38295313-C2F81EB3-96B7-4325-820F-1C578BC1A2C5Q38718976-01A2AC1F-8365-4FFB-B7B8-BEA0287FEB23Q38788986-DBB3DBFA-B300-417A-B7F4-2373C5C19C5FQ39610958-6428FEC5-8DFB-49A5-ADCA-B366090FBA98Q40510362-1A83DF07-26D1-47D7-AF86-F5B0C5157AD9Q41050086-4F619B73-636A-47DB-894B-47876A5794D0Q41089560-ADB2CE59-A507-4AD3-A565-6171DE49188AQ42209140-649162AC-5FAB-493A-B12D-479D031E3341Q43170560-81B9DBFE-5A9F-4FDA-BD72-B1F21FA60C45Q43299530-641E0F55-AA19-403A-A3D1-DD3B26E61F75Q44228860-EF373C07-CFD7-4735-B677-D2CFD151C714Q44520958-9A9141C6-C02D-4278-80FE-98D6388C8982Q44682457-768AB1D4-303A-4088-BBF6-83808EA43438Q44913212-168C8D0E-A622-4619-990E-1277A0D7679EQ44921023-186075C7-584A-439B-BFA4-39CE847743E0Q46489524-FC6715F2-41F6-45A4-9B8B-756299469E92Q46633708-5502E27A-DDC7-4190-BD34-C2EE48FE9AA9Q47841344-148A6BCF-C3A7-4E03-A8B7-B94BCA79E306Q48179204-AEEB40EE-9AF9-4B33-901F-5536465F50E6Q50239436-C5C810A6-CBEC-4E42-A405-8742E4A266FDQ50593742-EC8DD1E7-A9F0-4FE4-BB65-5CCD553FB8B4Q53041595-5BE2B2CB-6F65-4504-92D1-BB9958F16DB9Q53526711-9AB6556E-DAA0-49F2-9F5F-65D17CE7EEABQ53589137-8B830F06-42FF-4174-AF81-362280507961Q79983148-DE57AF7D-0782-4672-954C-D33FD21FC57FQ96603884-1F2FE50A-B934-4E03-A52A-D553AB5E950F
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Roberto Canaparo
@ast
Roberto Canaparo
@en
Roberto Canaparo
@es
Roberto Canaparo
@nl
Roberto Canaparo
@sl
type
label
Roberto Canaparo
@ast
Roberto Canaparo
@en
Roberto Canaparo
@es
Roberto Canaparo
@nl
Roberto Canaparo
@sl
prefLabel
Roberto Canaparo
@ast
Roberto Canaparo
@en
Roberto Canaparo
@es
Roberto Canaparo
@nl
Roberto Canaparo
@sl
P106
P1153
6603408709
P21
P31
P496
0000-0003-2774-6817